Notoginsenoside R1
Cat. No.：YN380232
CAS No. ：80418-24-2
| 产品名称: | Notoginsenoside R1 |
| CAS No.: | 80418-24-2 |
| Chemical Name: | (3β,6α,12β)-20-(β-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-β-D-xylopyranosyl-β-D-glucopyranoside |
| Synonyms: | Sanchinoside R1; Sanqi glucoside R1 |
| 分子量: | 933.13 |
| 分子式: | C₄₇H₈₀O₁₈ |
| SMILES: | C[C@]([C@@](C[C@H]1O)([H])[C@]2(CC[C@@H]3O)C)(C[C@H](O[C@@](O[C@H](CO)[C@@H](O)[C@@H]4O)([H])[C@@H]4O[C@@](OC[C@@H](O)[C@@H]5O)([H])[C@@H]5O)[C@@]2([H])C3(C)C)[C@]6([C@@]1([H])[C@]([C@@](CC/C=C(C)/C)(C)O[C@@H]([C@@H]([C@@H](O)[C@@H]7O)O)O[C@@H]7CO)([H])CC |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | 三七皂苷R1 (Notoginsenoside R1) 三七的主要活性成分，据报道有神经保护、抗高血压的作用。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Li, L., Zhang, J.-l., Sheng, Y.-x., et al.Simultaneous quantification of six major active saponins of Panax notoginseng by high-performance liquid chromatography-UV methodJ. Pharm. Biomed. Anal.38(1),45-51(2005)
Jia, C., Xiong, M., Wang, P., et al.Notoginsenoside R1 attenuates atherosclerotic lesions in ApoE deficient mouse modelPLoS One9(6),e99849(2014)
Zou, S., Zhang, M., Feng, L., et al.Protective effects of notoginsenoside R1 on cerebral ischemia-reperfusion injury in ratsExp. Ther. Med.14(6),6012-6016(2017)
Zhang, J., Ding, L., Wang, B., et al.Notoginsenoside R1 attenuates experimental inflammatory bowel disease via pregnane X receptor activationJ. Pharmacol. Exp. Ther.352(2),315-324(2015)
